• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

11. 慢性肾脏病与风险管理:糖尿病医学诊疗标准-2022 年版。

11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.

出版信息

Diabetes Care. 2022 Jan 1;45(Suppl 1):S175-S184. doi: 10.2337/dc22-S011.

DOI:10.2337/dc22-S011
PMID:34964873
Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

摘要

美国糖尿病协会(ADA)的“糖尿病医疗护理标准”包括 ADA 当前的临床实践建议,旨在提供糖尿病护理的组成部分、一般治疗目标和指南,以及评估护理质量的工具。ADA 专业实践委员会(https://doi.org/10.2337/dc22-SPPC)的成员负责每年更新护理标准,或在有需要时更频繁地更新。有关 ADA 标准、声明和报告的详细描述,以及 ADA 临床实践建议的证据分级系统,请参阅护理标准简介(https://doi.org/10.2337/dc22-SINT)。希望对护理标准发表意见的读者可在 professional.diabetes.org/SOC 进行评论。

相似文献

1
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022.11. 慢性肾脏病与风险管理:糖尿病医学诊疗标准-2022 年版。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S175-S184. doi: 10.2337/dc22-S011.
2
17. Diabetes Advocacy: Standards of Medical Care in Diabetes-2022.17. 糖尿病倡导:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S254-S255. doi: 10.2337/dc22-S017.
3
7. Diabetes Technology: Standards of Medical Care in Diabetes-2022.7. 糖尿病技术:《2022 年糖尿病医学诊疗标准》。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S97-S112. doi: 10.2337/dc22-S007.
4
16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022.16. 医院中的糖尿病护理:《糖尿病医学诊疗标准-2022》。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S244-S253. doi: 10.2337/dc22-S016.
5
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.2. 糖尿病的分类和诊断:2022 年糖尿病医疗护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. doi: 10.2337/dc22-S002.
6
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.10. 心血管疾病和风险管理:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S144-S174. doi: 10.2337/dc22-S010.
7
6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.6. 血糖目标:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S83-S96. doi: 10.2337/dc22-S006.
8
13. Older Adults: Standards of Medical Care in Diabetes-2022.13. 老年人:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S195-S207. doi: 10.2337/dc22-S013.
9
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022.15. 妊娠期间糖尿病管理:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S232-S243. doi: 10.2337/dc22-S015.
10
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.12. 视网膜病变、神经病变和足部护理:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S185-S194. doi: 10.2337/dc22-S012.

引用本文的文献

1
Seed Residue Extract Restores Gut Microbial Balance and Enhances Insulin Function in High-Fat Diet and Streptozotocin-Induced Diabetic Rats.种子残渣提取物可恢复高脂饮食和链脲佐菌素诱导的糖尿病大鼠的肠道微生物平衡并增强胰岛素功能。
Int J Mol Sci. 2025 Aug 22;26(17):8176. doi: 10.3390/ijms26178176.
2
Association of immune-inflammation indexes with incidence and prognosis of diabetic nephropathy: a systematic review and meta-analysis.免疫炎症指标与糖尿病肾病发病率及预后的关联:一项系统评价与Meta分析
Front Endocrinol (Lausanne). 2025 Aug 18;16:1532682. doi: 10.3389/fendo.2025.1532682. eCollection 2025.
3
Effectiveness of Sodium-Glucose Transporter 2 Inhibitors and Semaglutide on Body Composition in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Real-World Cohort Study with Bioelectrical Impedance Analysis.
钠-葡萄糖协同转运蛋白2抑制剂和司美格鲁肽对2型糖尿病和慢性肾脏病患者身体成分的影响:一项基于生物电阻抗分析的真实世界队列研究
Diabetes Metab Syndr Obes. 2025 Aug 15;18:2885-2897. doi: 10.2147/DMSO.S531413. eCollection 2025.
4
Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist, in patients with non-diabetic CKD.新型非甾体类盐皮质激素受体拮抗剂非奈利酮治疗非糖尿病慢性肾脏病患者的疗效观察
Ren Fail. 2025 Dec;47(1):2545939. doi: 10.1080/0886022X.2025.2545939. Epub 2025 Aug 12.
5
Uric acid to high-density lipoprotein cholesterol ratio is associated with the prevalence of diabetic kidney disease in euthyroid patients with type 1 diabetes mellitus in China: A multicenter cross-sectional study.尿酸与高密度脂蛋白胆固醇比值与中国1型糖尿病甲状腺功能正常患者糖尿病肾病的患病率相关:一项多中心横断面研究
J Diabetes Investig. 2025 Sep;16(9):1683-1691. doi: 10.1111/jdi.70107. Epub 2025 Jun 27.
6
MyμAlbumin: A Cutting-Edge Immunoturbidity-Based Device with Real-Time and Seamless Data Transmission for Early Detection of Chronic Kidney Disease at the Point of Care.MyμAlbumin:一种基于免疫比浊法的前沿设备,具备实时无缝数据传输功能,用于在医疗现场早期检测慢性肾病。
Biosensors (Basel). 2025 Jun 17;15(6):391. doi: 10.3390/bios15060391.
7
Albumin-To-Creatinine Ratio Underestimates True 24-Hour Albuminuria in Obesity: Clinical Relevance for Vascular Risk Stratification.肥胖患者中白蛋白与肌酐比值低估了真实的24小时蛋白尿:对血管风险分层的临床意义
Diabetes Metab Res Rev. 2025 Jul;41(5):e70064. doi: 10.1002/dmrr.70064.
8
Association of Albuminuria Within the Normoalbuminuric Range With All-Cause Mortality in People With Type 2 Diabetes.2型糖尿病患者正常白蛋白尿范围内的白蛋白尿与全因死亡率的关联
Diabetes Metab Res Rev. 2025 Jul;41(5):e70061. doi: 10.1002/dmrr.70061.
9
Construction of a PANoptosis-Related Gene Signature for Diabetic Nephropathy.糖尿病肾病全凋亡相关基因特征的构建
Kidney Blood Press Res. 2025;50(1):496-512. doi: 10.1159/000546764. Epub 2025 Jun 12.
10
Genetic Variability in Cisplatin Metabolism in Kidney Injury in Patients With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiotherapy.接受根治性放化疗的头颈部鳞状细胞癌患者肾损伤中顺铂代谢的基因变异性
Head Neck. 2025 Oct;47(10):2683-2692. doi: 10.1002/hed.28179. Epub 2025 May 8.